GGrantIndex
Sort

53,477 grants matching addiction

Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor

$1,578,486
Lei Shi · National Institute On Drug Abuse · ZIA · FY2020 · DA

Yale/NIDA Neuroproteomics Research Center

$1,577,121
Kenneth Robert Williams · Yale University · P30 · FY2009 · DA

DRUG ABUSE TREATMENT EVALUATION CENTER

$1,576,486
University Of Pennsylvania · P50 · FY2003 · DA

Neuronal Ion Channel Modulation By Second Messengers

$1,576,117
Stephen R Ikeda · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA

The National Drug Abuse Treatment Clinical Trials Network

$1,576,093
Roger D. Weiss · Mclean Hospital · UG1 · FY2019 · DA

Building Social and Structural Connections for the Prevention of OUD among Youth Experiencing Homelessness: An RCT Examining Biopsychosocial Mechanisms

$1,575,267
Jodi L. Ford · Ohio State University · R01 · FY2025 · DA

Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling

$1,575,251
Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE

Chiropractic Care for Veterans: A Pragmatic Randomized Trial Addressing Dose Effects for cLBP

$1,575,084
Cynthia R Long · Palmer College Of Chiropractic · UH3 · FY2020 · AT

Wake Forest NCORP Research Base

$1,574,957
Glenn J Lesser · Wake Forest University Health Sciences · UG1 · FY2022 · CA

Center to Improve System Performance of Substance Use Disorder Treatment

$1,574,614
Sharon Reif · Brandeis University · P30 · FY2023 · DA

Developmental Exposure Alcohol Research Center

$1,574,290
Terrence Deak · State University Of Ny,Binghamton · P50 · FY2020 · AA

22/24 Healthy Brain and Child Development National Consortium

$1,574,012
Brittany Rollins Howell · Virginia Polytechnic Inst And St Univ · U01 · FY2022 · DA

Group-Based Mindfulness for Patients with Chronic Low Back Pain in the Primary Care

$1,573,624
Natalia E. Morone · Boston Medical Center · UH3 · FY2023 · AT

Developing GPR37 activators as non-opioid pain therapeutics

$1,573,491
Jun-Ho La · University Of Texas Med Br Galveston · R61 · FY2022 · NS

22/24 Healthy Brain and Child Development National Consortium

$1,573,427
Brittany Rollins Howell · Virginia Polytechnic Inst And St Univ · U01 · FY2023 · DA

17/24 Healthy Brain and Child Development National Consortium

$1,572,269
Sylia Wilson · University Of Minnesota · U01 · FY2025 · DA

Analgesic Drug for Local Delivery by Fluoroscopy

$1,572,160
Andreas S Beutler · Interventional Analgesix, Inc. · R44 · FY2021 · NS

Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS)

$1,571,023
Matthew Aalsma · Indiana University Indianapolis · R61 · FY2022 · DA

Whole person experience of pain: Novel integration with low back pain phenotypes

$1,570,904
Gwendolyn A Sowa · University Of Pittsburgh At Pittsburgh · UC2 · FY2025 · AR

Center to Improve System Performance of Substance Use Disorder Treatment

$1,570,208
Sharon Reif · Brandeis University · P30 · FY2024 · DA

Center for the Neurobiology of Addiction Treatment

$1,569,610
Michael A Nader · Wake Forest University Health Sciences · P50 · FY2016 · DA

Neurocognitive/Affective Correlates of Tobacco Dependence in Adolescent Smokers

$1,569,419
Stephen Heishman · National Institute On Drug Abuse · Z01 · FY2008 · DA

Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse

$1,565,840
David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA

COPA, an Automated Medication Dispensing and Remote Management System for at Home Methadone Dispensing

$1,564,357
John Timberlake · Berkshire Biomedical Corporation · R44 · FY2023 · DA

Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics

$1,563,778
Seok-Yong Lee · Duke University · R61 · FY2024 · NS